Literature DB >> 16111474

Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.

Tao Hu1, Muthuchidambaram Prabhakaran, Seetharama A Acharya, Belur N Manjula.   

Abstract

Our recent studies on PEG-Hb [poly(ethylene glycol)-Hb] conjugates generated by thiolation-mediated maleimide-chemistry based PEGylation demonstrated that the vasoactivity of the PEG-Hb conjugates is a function of the configuration of the PEG chains on the surface of the protein and is independent of the PEG/protein-mass ratio [Manjula, A. G. Tsai, Intaglietta, H.-C. Tsai, Ho, Smith, Perumalsamy, Kanika, Friedman and Acharya (2005) Protein J. 24, 133-146]. A Hb conjugated with six PEG5k chains (SP-PEG5k)6-Hb, was vasoinactive. In an attempt to understand whether the chemistry of conjugation of PEG to Hb has any influence on the modulation of its functional and solution properties, we have now generated a new hexaPEGylated-Hb, (propyl-PEG5k)6-Hb, by reductive alkylation chemistry. CD (circular dichroism) spectral measurements indicated that the overall secondary structure of Hb is not adversely influenced upon PEGylation. (Propyl-PEG5k)6-Hb exhibited an increased O2 affinity with decreased co-operativity and decreased modulation by allosteric effectors comparable with that of (SP-PEG5k)6-Hb, although its Cys-93(b) is not derivatized as in the latter. On a molecular mass basis, PEG linked to Hb by reductive alkylation increased its COP (colloidal osmotic pressure) more efficiently than when linked by thiolation-mediated maleimide-chemistry. These results demonstrate that the functional properties of PEG-Hb conjugates may be a direct consequence of surface decoration of Hb with PEG, but are independent of the site (pattern) and/or the chemistry of PEGylation. However the solution properties of PEGylated Hb are influenced by the site (pattern) and/or the chemistry of PEGylation and the presence or absence of an 'extension arm' between the conjugating site of Hb and the PEG chain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111474      PMCID: PMC1316295          DOI: 10.1042/BJ20050663

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  The prospects for red-cell substitutes.

Authors:  H G Klein
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

Review 2.  Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology.

Authors:  J G Riess
Journal:  Chem Rev       Date:  2001-09       Impact factor: 60.622

Review 3.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

4.  Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive.

Authors:  Seetharama A Acharya; Joel M Friedman; Belur N Manjula; Marcos Intaglietta; Amy G Tsai; Robert M Winslow; Ashok Malavalli; Kim Vandegriff; Paul K Smith
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2005

5.  Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain.

Authors:  B N Manjula; A Tsai; R Upadhya; K Perumalsamy; P K Smith; A Malavalli; K Vandegriff; R M Winslow; M Intaglietta; M Prabhakaran; J M Friedman; A S Acharya
Journal:  Bioconjug Chem       Date:  2003 Mar-Apr       Impact factor: 4.774

6.  Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

Authors:  P Bailon; A Palleroni; C A Schaffer; C L Spence; W J Fung; J E Porter; G K Ehrlich; W Pan; Z X Xu; M W Modi; A Farid; W Berthold; M Graves
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

7.  Cys-93-betabeta-succinimidophenyl polyethylene glycol 2000 hemoglobin A. Intramolecular cross-bridging of hemoglobin outside the central cavity.

Authors:  B N Manjula; A Malavalli; P K Smith; N L Chan; A Arnone; J M Friedman; A S Acharya
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

8.  Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds.

Authors:  L S Lee; C Conover; C Shi; M Whitlow; D Filpula
Journal:  Bioconjug Chem       Date:  1999 Nov-Dec       Impact factor: 4.774

Review 9.  Chemistry for peptide and protein PEGylation.

Authors:  M J Roberts; M D Bentley; J M Harris
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

10.  Preparation of well-defined bovine polyhemoglobin based on dimethyl adipimidate and glutaraldebyde cross-linkage.

Authors:  Tao Hu; Zhiguo Su
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

View more
  12 in total

1.  Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation.

Authors:  Dongxia Li; Belur N Manjula; A Seetharama Acharya
Journal:  Protein J       Date:  2006-06       Impact factor: 2.371

2.  Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin.

Authors:  Tao Hu; Belur N Manjula; Dongxia Li; Michael Brenowitz; Seetharama A Acharya
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

3.  Combining the influence of two low O2 affinity-inducing chemical modifications of the central cavity of hemoglobin.

Authors:  Parimala Nacharaju; Joel M Friedman; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochemistry       Date:  2007-03-24       Impact factor: 3.162

Review 4.  Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.

Authors:  Michael Brad Strader; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2016-10-20       Impact factor: 8.401

5.  Preparation of ultrapure bovine and human hemoglobin by anion exchange chromatography.

Authors:  Guoyong Sun; Andre F Palmer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-02-26       Impact factor: 3.205

6.  Tangential flow filtration of hemoglobin.

Authors:  Andre F Palmer; Guoyong Sun; David R Harris
Journal:  Biotechnol Prog       Date:  2009 Jan-Feb

7.  Hexa-thiocarbamoyl phenyl PEG5K Hb: vasoactivity and structure: influence of rigidity of the conjugation linkage on the PEGylation induced plasma expander-like solution properties of PEG-Hb adducts.

Authors:  Fantao Meng; Belur N Manjula; Amy G Tsai; Pedro Cabrales; Marcos Intaglietta; Paul K Smith; Muthuchidambaram Prabhakaran; Seetharama A Acharya
Journal:  Protein J       Date:  2009-06       Impact factor: 2.371

8.  Site-selective glycosylation of hemoglobin on Cys beta93.

Authors:  Yalong Zhang; Veer S Bhatt; Guoyong Sun; Peng G Wang; Andre F Palmer
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

9.  PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.

Authors:  Fantao Meng; Amy G Tsai; Marcos Intaglietta; Seetharama A Acharya
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-03-06       Impact factor: 5.678

10.  Improving cardiac function with new-generation plasma volume expanders.

Authors:  Surapong Chatpun; Parimala Nacharaju; Pedro Cabrales
Journal:  Am J Emerg Med       Date:  2012-08-03       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.